Home › Funds › Integral Health Asset Management, LLC › VRTX

Integral Health Asset Management, LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Integral Health Asset Management, LLC reported holding 40,000 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$19.9M, representing 0.89% of its reported portfolio and ranking #36 among its reported holdings. Integral Health Asset Management, LLC has disclosed VRTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)40.00K sh
Reported value held$19.87M
Portfolio Weight0.89%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Integral Health Asset Management, LLC's VRTX position evolved

Integral Health Asset Management, LLC first disclosed a stake in VRTX in Q1 2026 at 40,000 shares (US$17.9M). The position peaked in Q2 2026 at 40,000 shares, worth US$19.9M. Across 2 filings, Integral Health Asset Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 40,000 shares valued at US$19.9M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 40.00K $17.86M New
Q2 2026 40.00K $19.87M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Integral Health Asset Management, LLC held VRTX?

Integral Health Asset Management, LLC has disclosed VRTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Integral Health Asset Management, LLC's current position in VRTX?

As of Q2 2026, Integral Health Asset Management, LLC holds 40.00K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $19.87M, representing 0.89% of its reported portfolio and ranking #36.

Has Integral Health Asset Management, LLC been buying or selling VRTX?

In the latest 13F filing (Q2 2026), Integral Health Asset Management, LLC held unchanged its position in VRTX. The position peaked in Q2 2026 at 40.00K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.